throbber
11.8. TRAI)F.\'IAR1\' APPLICATION NO. 78967470 — GOOD HEALTH NATURALLY
`
`Page 1 of 2
`
`T0:
`
`GOOI) III£AI.'1‘H NA'I‘URAI,I,Y, INC. (m§\\/y_ecr_s@,S_wyeLs_Iav;/.c0m)
`
`Subject:
`
`U.S. TRADEMARK APPLICATION NO. 78967470 — GOOD HEALTH
`NATURALLY - 03-0584
`
`Sent:
`
`3.~"15/2010 2:00:33 PM
`
`Sent As:
`
`ECOM114@USPTO.GOV
`
`Attachments: A_ttaehment - 1
`Attachment — 2
`
`Attachmc1,1t_—, 3
`Attachment - 4
`
`Attachment - 5
`
`Attach_mcnt_: 6
`Attachment - 7
`
`Attachment - 8
`
`Attachment - 9
`
`A_t_tachment_-N 10
`Attachment - 11
`
`Attachment - 12
`
`Attachment: 1311
`Attachment - 14
`
`Attachment - 15
`
`ALtachInctI,1t_-I 16.
`Attachment - 17
`
`Attachment :E
`
`A__ttachAment_-Z 19
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`SERIAL NO:
`
`78/967470
`
`1\»1ARl(: GOODHEALTHN1\»1~LIRALL\»
`
`(,‘.()RRI<ISP()1\'DEN'1‘ ADDRESS:
`~\‘1A'1'1‘H1'3\‘V 11- SIWERS
`
`I
`"
`'
`RESPOND TO THIS ACTION:
`
`THE SWYERS LAW FIRM, PLLC
`344 M.~'\1’I .1‘,
`.\V1*LN1II-1 WI*'.S’1‘, SUITE 389
`
`VH=NNA= "A 23130
`
`h_t__tpI//$1“!“I:1JVSpt0_g0v/{£as]g'LE‘1\SJ1agel)_htn-I
`
`GENERAL TRADEMARK INFORVIATION:
`
`http://www.uspto.gov/main/trademarks.htng
`
`APPLI(‘.A1\"l‘:
`Nz\'1'LIRALLY, INC.
`
`GOOD IIIEALTII
`
`C()RRESPONDENT'S
`REI*‘I*IRl<II\'C E/I)()CKET NO:
`03-0584
`(‘ORRESPO1\'DENT E~MAIL ADDRESS:
`
`tile : ‘xtiers-ais—01 \tiersexp0It\HtmlTOTiffInput‘-.OOA0001 201 O_ 03A16_09 W24i4O_TTAB0... 3/16/2010
`
`

`
`US. 'l‘RAT)F,NIARK APPLICATION NO. 78967470 — GOOD HEALTH NATURALLY
`
`Page 2 of 2
`
`ms wy crs fa‘: Swy ersL aw . e om
`
`BEFORE. THE, TRIAL AND APPEAL B_0AR_D. QN APPEAL
`
`ISSUE/MAILING DATE: 3/15/2010
`
`AQ'I‘IQl_\7 TO_RF,T:[_,:RN,:I‘HE CASE
`
`T,O
`
`TRADEMARl§_TRlnAL Ab?D APPFIAL B_O_ARD_
`
`Pursuant to the liebruary 2, 2010, order by the Trademark Trial and Appeal Board, which granted the
`examining attorneys request for remand pursuant to 37 C.F.R. §2. l42(d), supplemental evidence is
`attached hereto.
`
`/ses/
`
`Shaila E. Settles
`
`Trademark Examining Attorney
`Law Office 114
`
`(571) 270.1527 (t)
`(571) 270-2527 (1)
`shaila.settles@uspto.gov
`
`RESPOND T 0 THIS ACTION: Applicant should file a response to this Office action online using the
`form at littp2Aiwwviuspggoygas/e1L1ASpageD.htin, waiting 48-72 hours if applicant received
`notification of the Ofiice action via e—mail. For technical assistance with the form, please e-mail
`TEi’\S(_t_iguspto.gov. For questions about the Ofiice action itself, please contact the assigned examining
`attorney. Do not respond to this Office action by e—mail; the USPTO does not accept e—mailed
`TBSIJOIISCS.
`
`It‘ responding by paper mail, please include the following information: theyapplication serial number, the
`I1’1tlI'l'x. the tiling date and the name, title/position, telephone number and e—mail address of the person
`signing the response. Please use the following address: Commissioner for Trademarks, P.O. Box 145] ,
`Alexandria, VA 223 l 3 -1451.
`
`ST.-\'l‘US CHECK: Check the status ofthe application at least once every six months from the initial
`filing date using the U SPTO Trademark Applications and Registrations Retrieval (TARR) online system
`at littpti‘/t.arr.u._spto. gov. When conducting an online status check, print and maintain a copy of the
`complete TARR screen. If the status of your application has not changed for more than six months,
`please contact the assigned examining attorney.
`
`tile:".r"\‘v.ticrs-ais-(Jl\.ticrsexp01’t\HtmlTOTiffInput\O()AO00l2010g03_il6i09i24i40_TTABO... 3/16/2010
`
`

`
`This Is Goggle-'5 cache of http'/!v~Mrw.gn»:.ccum/
`
`It Is a snapshot ofthe page as It appeared on Aug 6, 2009 2U11'18 GMT The current [zaqe could have changed in the meantime. Learn more
`
`These search terms are htghltghted: gnc
`
`Textaanly versron
`
`
`
`" =,
`
`$~|u»pp»nr1 [art [U U-'1 .
`
`]
`
`Entu keywutd or Item numbct
`s
`
`3E"‘”C‘* '
`
`DEAL OF THE DAY IT'S GOLD CARD WEEK!
`V
`K
`Save an extra 20% when you use your GNC Goid Card.
`MONSTER MILK "
`Protmn P-ywec
`
`Qon t have one’!
`3'9" “V ‘"‘d 3°"'°‘
`
` Introducistg
`
`
`
`
`
`LnI’\|C, /\UY(.} (355 L iV!7I«W Q
`-.!t’'.
`,»u...
`
` ‘[‘X‘ W
`
`, t,
`.
`
`Liu'\V\tH L1-Jntcr X"Vi.f/MD
`
`V H
`:14““V f-
`; -
`v".‘2;;r"
`- 5 ways Wtamin 0 Could Save Your Life. Lr MI
`- Using sunscreen every day may result in Vrtamin D deficiency. LB 1' ‘I two
`
`
`
`
`
`The World's Best
`Acal & Resveratrol

`
` See It First
`~ Nat1'0ne'tI|y:xtGNC
`NEW Extreme
`J§"f,',‘o":'L‘f;;?e‘5
`
`In The_ News —
`Vitamin D
`Experience the
`
`
`tenefits
`
`
`

`
`-,
`
`’
`
`.
`
`I’
`
`.2
`
`I
`
`-«
`
`pr
`
`:~+u~
`
`I‘
`
`.
`
`2.
`
`, =4:
`
`2
`
`4
`
`..._.
`
`..
`
`Jun!
`
`:1
`
`‘»h1.ppu1<_)Cur( [H H :1]
`
`Enter keyword or Item number
`
`SUV“: ‘ '
`
`(ENC
`
`‘“...._‘
`‘m
` Home > Vntonuns & "Minerals
`
`
`
`\\;lIm-xs m|'arm.mm1
`from ,1 rrumd munc.
`L&'.’AI£N MUIIL -
`
`(ENC AUTO {)F;JVITF\\"
`
`“r
`
`I
`
`I
`
`BUY ONE, GET ONE 5o%oFP
`“I
`
`
`MI
`
`I
`
`‘
`
`
`
`Best~SeH=_~r;
`
`FREE SHIPPING AT 509
`
`New fvIuItwAt3rr\m5
`
`
`
`'_
`
`\
`
`featured products:
`
`suonuow >
`
`‘,
`
`,
`
`Daily Wullm--A K nmpunycnl
`
`‘JIta;IaI<:
`\'Ita,~mrI.- I-<-I
`
`M:n's Health
`
`'-.l\/'m1en'r Health
`
`Jnmr Suppufl
`
`»‘«rItIoxIdant;
`
`L.NL Prvvantwe Nutrltruwr)
`[u[)— 10 5Dn
`.. I
`- 1‘
`1»
`I «..:p-.n|av:-
`
`32239
`
`
`
`
`
`V
`
`I‘ 1'‘
`
`H ,
`‘
`
`v
`
`..._
`-..
`‘=3'—"’>
`Irsnrer m I
`
`ENC Triplv strength Fish ‘ um Trifle:-z M Sport
`9'‘
`
`
`
`- 335.99-54.99
`‘v
`MN 32939.
`
`. ‘ UN“ in" ‘ w
`
`ENC r-Ir.-qu Mm1‘V3‘Spurt
`Vutapaké
`
` I
`
`.1, $49.99
`$44.9‘;
`$35.99
`Hm mil‘.
`
`
`
`.
`
`l”.NL‘Won1cn's Ultra ML-gaunfr
`nctwa Vutapakvjl
`
`-$49.99
`w.
`$44.99
`;«
`i
`.,
`|II_;',3 535.99
`I
`:\»,<'!«: 3%»: om smw
`on .u.‘,‘
`
`
`
`LINL Wurncu'sHaIr,9k1nlS:
`y,. __
`Nails Fnrmulu BONUS SIZE
`
`
`
`'s
`
`$13.99
`M _.
`r 515$?
`‘
`-
`-
`v;‘m.'
`,
`
`
`.:
`
`UM w[LLbz:L\G" Wuqht
`‘£43.
`Mquaqc~n1cnI: Turboklt
`
`
`
`:-m rm»
`7
`A
`*‘|
`
`I
`'-
`-
`

`
`399.99
`$79.99
`vi
`=1:-‘.z‘L‘w;’
`
`Ix
`
`
`
`Fish 0.1, Flax a
`.=Eent|aI Fatty Acids
`Dtgestvon
`
`Heart Health
`
`C':|CIUI'1’|3eM|f'1>2V3]S
`
`Speualty Supplements
`
`SAVE 20% TODAY '
`rmo our now u
`
`‘
`
`'
`
`
`
`,_
`)
`_,
`w;=xw:.<
`at I
`- Jr;
`
`
`
`
`
`32%/\N_) OI“ VIE MON ll‘-I
`“8"~‘ NORDIC NATURALS
`’
`
`Vitamins & Minerals
`
`I
`
`'.ymm m I Inllu n;
`-,-ou uru
`'-='h~i|-.42:
`III-[I|FI1{:I'!I' Ind I‘~IT]
`I]'I Ihr‘
`rlxe _.rJnd.-m‘J Ir. Uh.‘
`’ n X4 ~r‘-I
`.,
`
`
`.II'h> <r.m1,
`.1!-" ‘In-urn I H‘--vrfl. In alfh and L-um’-vn‘r IIr—.aI*h Cr
`In m
`iwmmm-vy, §up;\rr*i
`_
`IL :1 M.
`“av
`:‘.t1n'.(.m:
`1.: L41” 1:‘: ~3H )f‘;uv'..I1r.’Ir.u nd mvn:-r.:I=
`1" 3:1 1‘;-v. fcflr v :- ha ~= v.-hat
`L J1!
`-'4 "
`
`
`-.r'\.:mr\ more
`.
`.“ multivitamins 3r-1 '1;-:aIi'1,« ~ mg.‘ » nv v~:w.,
`A
`I.
`,1 ‘H41 H-‘L -.
`2
`'.
`‘,‘."I‘n_ It I.
`r wI<.r
`.lv
`
`‘VI‘
`
`!—m- U,‘
`
`
`.'rcvr..»-I'’
`.«
`.’I
`L
`A.
`
`F41 gar -w
`‘xvi:-I-:1HUYlIYI|n':v'I|(v*l
`'
`.
`.M&Iflv.~e
`U SEFURE
`Hm‘. ~' nu-
`
`-’i
`
`Im
`
`.11-~-I
`
`{ma r. Rm It-»n.:
`
`AMI: .n
`
`

`
`
`
`:r.~ mr
`
`wt’
`
`‘.1
`
`r
`
`Shappknq art In n--r,~. -]
`
`Enter keywmd DI rem number
`p
`
`IVEJWCN '
`
`
`Home .
`rm»! 5uppnI1 Formulas
`
`
`
`.
`
`2 mm mm '
`
`§.y{)/)MD
`l.i\«_-\\«,-IlCc1xtcI‘
`\Xc|h1m.«nn|unn.nmn
`{mm .1 umu-sl wunr.
`.cAr..*« Iuum >
`
`Diet support
`For-vnulas
`
`Show mt‘:
`
`TupSa1$ers
`
`;;Jr
`
`VIEW all 59|tr:n1s
`
`[H2 345‘
`
`Quid<Tr-im Burn IV Cleanse
`‘
`
`‘
`
`G|axnSmithKline c|"i®
`Refill Pack
`
`‘,
`
`349.99
`w
`$39.99
`-m .»
`minis ,~.«.‘,
`. n
`':.~.s&«
`
`811
`
`
`
`
`
`Slln1quh:k"“ Ext-am:
`.\1.‘\.,
`
`Jillian Michael: EXTREME
`QUICKSYRRT Rapid
`Weight Lass Program
`5:!
`
` um‘ r‘ “
`
`4 .4‘.~ saw-. 359.99
`‘
`1.
`$52.99
`,1 uni.’-‘

`$42.39
`In v ‘
`I zgngurux :-11
`x‘:'eIvr< my ~-gm 52;‘
`
`Revolulion Abdominal
`Cuts
`.
`'
`'
`—
`
`ENC WELlbclNG.""
`Wenght Management
`Turhokit
`
`
`
`
`
`ENC Lhilnsan wlfil
`Glucumannan
`'.
`--
`;[.~,u'..
`
`§3W“‘
`
`2
`
`'~_:
`
`l’.IaxoSrniH’IKhnu aIlI®
`Starter Pack
`An‘
`y,;M .
`
`.: mE§X,\~'ii-‘7~'
`

`
`ENC Pro Perfon-nance®
`I:Ln.
`
`GNl:Tonalln® CLA
`'*
`1"‘-vw )1 »‘.‘<:
`
`
`
`324.99 -
`u '
`w
`3999
`.1. mm: $19.1m-
`31-"
`-“~‘ --
`$25.59
`mo»
`xi‘
`W CA.
`§$Ul~hn‘ » “
`
`1
`‘,
`
`xnum-
`
`--
`
`Imp 321.99
`$13.09
`..1 p.‘
`315,19
`v.""'. :: an
`H§‘H‘=.41‘
`,
`
`-.
`6
`
`‘
`
`‘.
`
`
`
`
`‘
`,.
`\"~
`
`ENE Weight Managexnent
`Starler KR
`‘_
`W
`
`————..——
`‘:.‘I|I>
`
`'-'
`'
`I
`“
`frw HIM:
`"
`'
`«>1
`in
`
`
`
`1
`1

`
`SlIrnquic|<""
`,1: ‘)
`T‘ ‘
`’
`
`$49.99
`M »
`$36.99
`'~‘ "
`l1zv'L‘
`329.59
`‘
`w
`;:~ .- nmgn inc: un
`:.~z:.~-~
`a e =x‘~ M
`4.
`
`view all 5‘) Items
`
`[112 3 -1 5‘
`
`Diet Support Formulas
`*' m.» In.-*5 '- _ 1'. ugh?“ M «. mhw; u:'\'.1
`:.7v;n yr x)’.Iv~, to um 1-
`‘K44’
`-v M my *1: iii
`v
`- am nu .npmt.m mm -59: H pr. sh--;:_ 4,».
`
` .- w.» r ,r hclp. M.-n~,
`cv1"I"1:€ gnd
`nyurr.
`suha nt,*-
`.1‘‘.'
`‘J‘‘
`‘>'.'
`
`
`
`
`‘wwic « -2-2'
`Turn’ 3-!‘
`1‘.
`[W4
`h mun .v
`5}? ~:' U?‘
`
`
`f
`
`u
`
`At-11.
`
`A! a‘
`,r.-
`I.|«.
`F...“ -_
`',y..
`\«1I.‘ Vmzur ., c.,n,.._ 1: ;.
`‘Mall
`'3‘ S{1:1)§E
`Iuu.. 7» I’.
`
`

`
`r~.~«‘r.
`
`WW‘: -sold C arci
`
`-3Nr.“ Gift Card
`
`Store Locntor
`
`Shop By Category
`
`M-,« A::cc~unt
`
`Site Map
`
`Shopping Cart [0 firms]
`
`Enter keyword or item number
`..lxd _.
`.
`
`SEARCH ‘
`
`. H
`
`(ENC:
`
`V
`
`V
`
`ome > About GNC >Sbnre Locabor
`
`U E
` " 1. ETF EET
`
`:,Am)ut ENC
`—GNC Qualcty
`— Company‘ History
`.
`~ Investor Relatlons
`-Press Releases
`- Franchise Information
`
`‘ Ernplwrrnent
`- Charitable Efforts
`-Verdors
`_
`
`“are Locatw
`
`Back to Map > 20036
`
`STORE LESTIN(§S BY EESTANCE
`‘urtal cod‘. *0
`
`‘
`WASHINGTON
`

`0'9 ”"‘”
`
`v,-AsH1N(3ToN
`
`0.»:nrx1»I.;_
`
`WASHINGTON
`
`0.; :~~m..s
`
`-.«..:-:HxN~3TOr~¢ .‘:'-F 20036.
`“"*“’—” ‘-“:3 “"57‘°‘7‘:'7
`c-Lmcrur c1PcL:
`1.330 ccumrne ;TI< UT «wt. NW
`
`-
`'-«CHINGT-DN .:: '-0-3:<c.
`Phonzci (2021 ‘/7"5-.'.“Z-,7}
`
`emu:
`
`
`Get map
`
`.
`-
`Get D‘ra°t'°”5
`
`Get map
`
`Get Directions
`
`Get map
`
`Get Directions
`
`1
`
`:: .“.’-Gfilx,--37Uf_"\
`
`Contact um;
`
`Terra: 9: -Tondmons
`
`Pnuacy ‘sratenaent
`
`Abwt GNC
`
`Careers
`
`Investor Relatnons
`
`Affmavzes
`
`-33997-2009 General Hutunon -Tent:-r-‘. Inc.
`
`
` ‘ : Eucl’-UH
`
`W 5('l,1;‘(‘E
`lL.‘Il1{3Z!r-;\ll‘C.
`
`
`
`
`
`
`
`i
`
`
`
`

`
`Thxs ls Guugle‘s cache of
`hrmtllwwgvsandpworld.wa|Ist.comlmarkets/com;;an3dccompany.asp?caplQ|d=319092
`.h we a snapshot nfthe page as It appeared on Aug 10,2009 015633 GMT‘ The
`QE9_T!L!1Q!L§
`could have changed m the meantime
`Lean mote
`
`These search terms are highlighted perrigo analgesic
`
`‘'
`"
`*'
`
`]'_a_gt;g_r1l_y_v_gr§_i_t1nV
`
`
`
`Company Name, Symbol, Exchange or Country
`iv ADVAN=EEI'2 SEAMZH
`I'UIl$.i
` CapitalIQ
`A n..;~-, .. ‘.- V.)I\nLI\’3 A: lxwk
`" ’ K0.‘ ll {*3
`
`
`
`i}<&‘H.*\§5DF P510: fl [3
`
`‘I
`
`STANDARD
`&POOR’S
`
`World Stock Exchanges
`mm 5' .1‘./GE
`
`Prml tins pa1]k"'
`
`Linking
`. institutional
`;lnvut1pr¢with- '
`Management:
`
`..m.4-g::m.m.n
`
`(Ewes view
`
`@155 Company
`(PRC-D:
`Nasdaa Global Market
`
`3-]
`
`!1‘xsm$:;u'\y F’v'of§h:
`
`Dublir
`
`f.-,.lUU
`
`E
`
`L‘=!5”’d ‘|7'“’*“~
`
`m~..e5:sh L. Iusgao
`
`“W 7
`,
`Chdsrnium
`
`CMIBI’ ’
`eL‘uLivC Olfiwi‘
`57:‘:-".i(§eni'
`
`Rt‘V(‘I\lH"
`(‘r‘m)
`‘:‘.2.18
`
`1 39 I
`Ht“Jr"l\£ll‘
`§=m'rrm (TIM) mnwm (; Yr‘;
`$3Z6.DM
`ZSJEN.»
`
`NM Hmrcxnw
`(WM)
`‘.~13i.u.CxM
`
`i'§1~kurn on
`fmmy 1,1‘! M)
`16.059»
`
`iota] Uvhi
`(mm);
`$1190.93"!
`
`; :3;-t:.x$mI l'm‘mcl d--:
`) b~;!xma\.:v.
`
`V
`v
`
`> Pnrv, Ll-mrt«.. 2:.
`
`:m«:-, v
`
`) lrwlzsiot‘ Rtlhxhom.
`
`) (ompany Nx-wn
`
`V
`
`v
`
`3‘r:m.\ry (|u‘}x:~Jr,I(s):
`
` "
`
`
`
`"
`
`
`
`
`
`Perriqn -
`mm .
`‘
`»."(u‘~» ,
`
`.
`
`. 1v! :1 mat ,1":_.
`mu‘ mm.
`‘ ppm ;~u.<m..»
`
`
`
`.
`.11] Vwwl vm
`.,-.3,m.m.n-fA:1
`'I4‘«|r»;v(’:n‘: 0.17.;
`
`.w3vm"S "
`gm} N’ I
`v
`
`V
`
`
`
`'
`E¥u»'Im'€s. Suxnmary
`
`Inucurnr ['r)nt;:c¥:
`kn '»'h1nnrn
`Fmullt
`cxysluunnonuxrperrlguma... v
`Phnru-:
`‘m n,
`1 it
`[‘rlM.'
`'73- "L57
`.1 ‘
`f\LIdl‘i'>§Z
`"91" F1
`am A rwn‘
`Am. .12”. H z,rm:.-v. 4 2[x;Lr
`:wxr_._n ;';'-1”
`
`
`
`_xJ
`
`Joseph C. Pnppd
`Perrlgu
`
`Perrigu
`
`Parrlgn
`
`Perrlqu
`
`na--5.".
`
`
`
`
`
`
`~ M-'Ivrn.my~-1?:
`
`‘r~ uyw
`mm‘: .9‘
`I'm twut-mu
`
` ~utcr.»3|r. .
`
`rm.» .L_'J..‘H'L
`.-1 .
`
`nvclu-.hnr,:
`.Lu|;»'x Lu ‘J:
`211 {min
`
`
`
`, :‘.h4rnL-no ,$1JLt‘Lv-\1J1r\.r'S ‘uuuj
`
`u’uun:., u. wr;H ,3; my
`‘- ma» h-_1:JnJs .mJ
`;fl.171Jl.A4'.‘ul ta, Ind
`r_1vm.'M' d
`The AH
`‘
`':1i5Qv-Hr 1:, drJ{1u k'J“! v
`
`
`

`
`«"(nq~».Iu«' in in'.Iv~.»‘ur~
`
`Pu.-du<.ls' um! 54;: viuas;
`
`- vlllgu
`
`‘I
`
`Y
`
`,
`
`.1,‘h
`dz.
`
`IP
`
`J
`
`
`
`
`fornumrr Hr-althcare
`Rx F’h.arrmucr~nfu'.=sls
`API Product;
`DU‘-.« rlnlmnz
`.~'r‘_
`‘
`.
`.
`
`L m
`‘L'Vl'\IfI'.LxL'.1‘
`7JlV}rJr
`
`.
`.
`.
`v— .
`-,
`y.
`‘.
`1
`‘I .-
`"v"-4.1.
`fm.-M,
`.1n.1:!v r‘. n =‘.. n.>
`"""' "
`
`>=
`
`i
`
`
`
`Us-uxrsminvxt
`Perrlgu ‘:0 .
`» Wt» zr
`.'
`.
`m
`'
`‘
`“
`'1:
`r
`..v
`v w
`mm L,
`1‘.
`’I'I.w..'.‘
`-v
`.rF.>xu'.
`~«f
`M and .PBrriqu- I-xv
`r.Imph»'
`w n
`.:1'3'
`‘
`Ar *1.-mu
`'
`“.~
`‘
`;
`nhlfl,
`‘M
`.-
`W
`
`A
`
`
`
`1
`',
`
`
`
`)-‘rr|~n( |'r(-an Rvl4>.xsA'st
`:A
`I nr mnru mmrvnamarx
`nh-.u.x> sow‘ l‘vrrmn‘s nvwv.
`and prcw l'('l(;u.‘:1.“$
`
`V
`
`D:'sII'§pHun:
`“w .‘w:'., n.
`Perrlgn *
`‘.
`‘_J'V}"‘.r'.‘.
`vv ml“!
`’
`vm’ '.
`V‘
`I‘
`‘L. " ‘
`‘
`r. "Hui;
`.‘ um . pr . FL
`n
`'v.~,'1uruv.;u,.:p nn.:l.;l
`Pm mu- '1 Q1 ml; 2
`-1. In -nnf-‘
`VJA
`\ _u
`u d /‘.w:, IH'J'."'-,"
`w
`I
`v
`\
`.4.
`/
`.
`.
`.‘- fvrv - J u."
`J
`H”: v.‘
`P‘,1'u.y .- u .t
`.T'
`vmuwvm
`{uni
`.’:,u mm M um um
`
`r.
`:v..
`pr .: rum . .u an
`._>.
`“
`‘
`:w\
`-,-v
`"
`‘
`'
`'-
`I
`
`"W ‘
`'1"
`5Dr«".
`
`RL’C(‘l)\'PT1‘S‘\RL‘lUd’~.L
`>i‘ornmrr mfurmutwn
`pix-ww ska’1’L‘r‘:’I4'j|')"~(|I‘W‘~
`and 1; -4-~.~.
`!'A‘]|'v|‘.yx'-
`
`
`
`
`
`Muar Dr‘{.n§;:
`J 1%.:-m.\ru~;' Wriy arr
`
`v
`
`V
`
`-1-
`
`HIlrl|5s'.'§c1lf;
`
`
`
`’
`v
`m—um.mnny
`\
`'*1.m.-ar:u*r)u:nl lflcglwv-mess ~
`,
`E-hJf;u';
`“
`
`n V
`‘ '
`~,;
`
`~
`
`4
`.
`
`-4 A
`
`.r, ...s~:\
`‘
`.
`<
`
`zenacv.
`‘
`‘
`mu.
`').11 sh.
`
`li.xl<mn- ‘ihrvl
`
`(ash I luv) E-tutu.-menl
`
`lm omc Malmnrnt
`
`V
`
`'-
`
`
`_]
`‘mp *; ‘}lx.u'&-huk!$.v::~.
`Hnshv in-‘am
`‘I./‘I'M:
`
`‘x‘/L‘”I!|qYL)H "’lu!x.1I)v‘|Hv’iIl
`
`Ruy1(%KJxs<»ur_x.Hu.
`
`10.?! “.'.>
`
`7.IC""o
`
`" V
`
`
`I L“(klH‘.' 1.1), -§ um:
`l\crw‘y: W,

`,|l7HI'>("1hPl'l
`~~ I-rv‘
`.
`‘ _Mn») \3Ik'I\hl‘t‘Ij -1-
`
`v. " " M r"* H”:
`, firwxjnry H.
`
`
`
`_ .n:
`[|m'!.r Hulrun W-:Iwr
`.
`,
`‘Mn

`~
`vv “‘
`w
`r Rand sli Hfnmrl-(y ( hf‘.
`_*.rnH Hurarh -
`Yn.w in -q.m
`L1‘-L~r<-.
`'
`Nu‘
`‘ aft’---rub “I “v um:
`i.$H1I‘rY
`'
`- U‘
`14*“ Dun}! I I). I-'li:'n
`9'
`
`tvw F'l~'.L.é 7'» ."H‘ldl’d-v.
`
`(«;r;mmH='
`
`I nwrnnmrn1'n)"
`
`1-~mx.mrnlyV
`
`

`
`mm».
`
`‘J,’
`
`._
`
`V
`
`>
`
`~..nm 'i>w.4 Y‘|l!lv~l1
`
`‘i.1«aI.a~liii~.iii~<,~,Im- ‘*I1.b<IlR.<“-)llJ|Ir1I'u|]lL'f
`A‘
`'11 i.'i4
`
`
`
`li
`
`*
`
`.. M
`
`\
`
`yam‘
`
`‘
`
`‘
`
`r
`
`‘-‘ zirn’
`
`<
`
`"V!
`
`I
`
`l
`
`>
`
`4.
`
`.4 “ Y
`
`..:»i I‘
`
`I.-11.1.
`
`v vrrw
`
`
`
`Iuvm-»
`
`..4 hlrn II!
`
`:65
`
`I
`
`i
`
`4
`
`Pm-I Ii! 1‘
`
` Lt-¢.iriiuhu1it5‘|«lL3l)'s S-II.lS|dii1|'I<‘\.
`lh1.‘i\I~)i1|s Md.
`v
`
`iwlxum»
`
`I-.:’.ii>I
`
`lianixluui‘
`
`X'rixii.xr-y Industry-(s):
`
`i.
`
`v
`‘
`»ii
`
`i
`
`.,
`
`
`
`'
`
`
`
`,r
`
`'.'.*ww.i:l'wiimii-,.i«iii:
`
`'
`
`<;iI5‘|
`
`JUEJI
`
`mliji-i.~.s:
`’;i-~. L.-.t
`
`[mi-i inui
`-l‘.MH
`I-.v )K‘
`
`If.I-"IV(.
`HI
`.iJ:ii.i wt.
`M » y_[r¥'w1ll4 i.
`.‘
`«hi-i...~ nib:
`rm for rm
`r.
`ri.. r~ 3.,,i'r._ .li,,i mm;
`.i-Jrin.-...,Jm ,r
`2w
`ifli;
`i' .4
`:y3u.1~d
`(“"1
`;n=-rru is Ami
`‘
`IU 11-.
`my i,m.‘i
`'
`«V
`“4Li‘JA|“i AH m,r.I H
`-. L: i-In-i.
`1' “vu ~, mu
`um“! -15 unn-
`...i
`. um
`,.\~ '
`.,
`‘
`i
`i.‘ Yli
`v’
`1
`I‘
`H
`‘
`L
`v,’.‘P
`H
`i
`_ pr -
`,,n
`H
`V
`in
`
`r
`4
`
`‘
`—
`
`_
`..
`V
`
`r
`

`
`‘
`
`.
`
`,
`
`v
`

`
`,
`
`.
`i.,‘
`,
`
`V’
`
`V
`
`;
`
`.5
`.
`
`,
`,
`~
`»~
`,
`..
`.
`I
`i
`v_
`4'
`am :
`,i M .4 »
`'
`«v
`.‘_:'i.'.
`1'1’
`Hr
`»'-“"¥:W.'iY“i
`'4'
`-
`'
`’~.H .
`rf Perrigo ' V
`
`
`
`
`
`
`
`
`I
`Y1‘
`x.
`
`,
`i..
`.
`
`.
`
`.
`
`V
`
`'
`
`i~
`.
`
`2.
`
`9
`‘,1
`_‘
`
`i
`
`'
`“
`-
`
`
`
`V
`'*
`i.»
`
`
`
`l\H'(*‘IlKi6‘ Md.
`Q|§H:IIL{i y 9 .n~:mici..i 5.0. d« F
`
`,.
`
`.
`
`»..mmyHua.inm.<. l)nsL'n'phor)
`‘>‘!nl—v“1di’Y ‘.1hn'¢=5 [HI .
`‘
`-'7
`.‘-
`’
`i
`r
`I
`N‘
`
`
`
`I
`IL
`
`_~
`
`.
`i
`.w'|
`:'..'-,vri.i'.~, .iu‘Jri.'iiu
`u‘.'.i'
`‘-‘i‘
`‘;:r.i':’-,“;r.fi.%ri
`
`

`
`ii
`
`
`
` I«)§r‘Dhl
`
`I‘-siiini
`rm~h2- in-Mn
`hidy Brawn
`mm I win»:
`Hlhdi’ —”1,\.\Yxl¢l
`
`~'
`~'
`H
`-v
`V
`
`Perriqo
`
`Puarrlgci
`
`s ~.*1nY‘»!§ in
`‘w‘:.u.n'.Jrd and Pnrii-K
`
` =w'in- 3! Um“
`H 2.; ins
`
`t\lbQl'hY I rrun
`4
`i,ni..:(~_:’iu~piir!.
`Copyright © 2009 Standard 84 Poor‘: Financial Services LLC, a subsidiary of The lvlifiraw-Hill Cainpaniss, Al rights reserved.
`
`

`
`jgar 9, cI:LII haze changed .n the meantxne
`
`
`
`T;:,I«LIL"iL *
`
`Dmw. TRAD§I_g(_)_I}tMtS_§ION
`I mzorecnlvc .~Ifi£'R1cA c CONSIIMITR
`
`.
`
`
`“"“"“' ‘*““’“ ¢V..t.'>’.¢-.1 ».c..~III;n I Enlsnafitl
`
`Pu_lity hdorntilotld
`Ec4}mlnIot_ Cotwtalcuuusat
`lrssxlrmluy I wIIIIums I lllmys I H6.-purtrrl Htrsalllclls ; Nutlcms (III I Stldlxll
`I, nmxl thn; Nnwsx l{lItI9.4I;re
`III,-cu send thls Imk la someone
`alas. IN: FTC w It not collect am
`pmsanal mtdnr 3II;rI anctn vm. at
`he ran: ant
`Related 0 cumnrl
`g wlllv
`.I~II.I.n! w
`
`
` s.l«
`..»II I.) '».IIc»
`.'
`
`
`
`FIIB Nu. 012 3121
`In tho Matter u1FnrrIga Cnmpaht
`1-
`I Inn!
` [var 431:1
`
`Fl!!! N0. U12 3051
`In the Matter Lima 5]
`Pharmaceutlcal Cnruorntmn
`
`‘ Ivor 53l«‘1
` I
`Hla Nu I112 3n;tll
`In thn Matter I:I1I,I‘I|l'I('I‘ HEat!I'I
`Plsdurls Inc
`
`
`
`l’. Ivar amq
`FIIH Na. D12 3058
`I
`In the Matter u1-Nlt
`In;
`
`I .I.~.,
`t
`(nor Ib6l3
`I-
`1
`It'll ,
`mu No. 012 3055
`In the Master n1l’I‘atFl atedhti-II
`FormuIatuns_ Int;
`I.nI.I -,
`
`
`
`
`I'ivrr Manufacturers of Over the—CoLIntcI‘ Analgesic
`PruIluI ts /\greI>. to Settle Cl}-II'I_)E‘i ol \IIIs|.IhI:lIItg Curtain
`I»-Irntlucts as "Mntle in USA"
`The [I]? campanlss that artuunt for nearly all ntlne pvllatfi hvand manuacmrlng nramlum-.1:
`
`grad
`In the unlted states have agreed In same Federal Trad» ;.umrmss=on mamas mt
`Ina. Ialsery Iepvesenlea that rertaln o1tneIrmeI—tnHounter407;) arIaI;IasI:s wet? made In Ina
`U"Il"'\l sm-.-> AmI.IrI.IIIIg lu lnv WC. many aim: ‘Made In USA" lililtlrhl [VDCUAJ5 IImt.IIrI
`Irnwrtssd at w InI1Iedrerl> (lluln asnnn, dCE'.dIVlII\'J[1l‘.El’Z_ U1 ItIuIIm'er Idmaoundat that
`mnslllulr a éubslanltal puflmn DlL'lEln2aIw:Io1lhE II Ilshed u'Ldu:.t~. The FTC allvglzb lhal
`11113 labelnng v-olatss the CnmmI5sIon's standard Ihat‘ Made In USA‘ Llanms be supported ht.’
`Evldente that the pmdurl IS ‘all urvlrtually all‘ dumestn alrr mace T"tE' prupased settlements Ir
`these case: wauld prdnInIl the nornpanlea tram rnlsrauresenltng lhr: etcnt to what‘ any utthzn
`
`OT: drug rrwdutls thal mn'aIn ana'gasI:.: are made ntre Lfilff-J 5
`u=mIaIII~ar rnnsI.rIe’s aw mare snnsmvla than way In tlatms ‘rat a mtmns mam In
`Amnnraf Sald Hrward EI>aIe£,DIre:tdrn1tt\s« HES. Bureau rt! I:-Insumer Prolvrllon '1 3
`tomnany Lhndses II: make an Nvtancarhmada claim, It stmuld tarnplywlth the Cummle sIon's
`standard Here, the hlgh level and nature ottne torelqn content exneed am reasonable
`meI-Imam urxre rnuanlnv U1 ‘Made In USA "
`Thu Respondents
`In eath tIHh>'«$P :a5r~s_ the FTC's tnmnlaxnr: allpga tn ztlhp mp Inmpames mtsraprpqpntvu
`lhal tartaln cI1trIaII anatunsln products wan: all 0lV\m1:‘|ll\/ all mam: In ll-Is, UnIIFfl Stairs whan a
`slgnmtanl nomnn at then rcmtant was ulturalqn nrlgln Nrnardlnu la the comulalhts. Ins attlve
`IHQIEIJIWII: ~ hulk asumn. aI.E‘lHVVI|flDKll'lE7|. dI Ibupruten LDIIVDDLIYIG: I Ital Itzspundsnts
`ulDEE'S:Ed IIID Iablels am ml were nade oI.II~.I:tI« tie Umtzd 3L1!t‘> Tra no "31 e:.u‘IIIrIed that
`the lI'lILlt.<fiEl! tlL.lK ll\|}7EIXlEIIl> Lurnanse in sutslanl al Le'( elttdde ultglal manuldtlurlnn [0215
`and II Man the HULIE<l analuaslc zualmtc Ihe UYC pmlucls at I: we Aitnrdlnnta me FTC alt at
`Ihe clalms aIe exprsss statements made on the Lump anIes' paclwtnng and Iab:«IIng, wltlch In
`somn Instannas were acmmnanled trv nlctuxs a mu 5 flags
`The CIImmIssmn’s cdrnplamts do not allege that all atthe IPSQUHUPHIE rmate label asnmn
`
`3tP(§'nlnIIplIul‘ and ltsllmnlnn mands ZIIF IT‘lsI2l’I9IP<:l {Ll .')r"vll\4l rpfla n rlrdljr \ 1|
`l’PR’~iIVI
`
`:IIsI;rveI< haw, nesn Irnpvnpsrwlauzlsa In .4U‘lllnr_l
`rr III 1 n I' LI‘KEVPI' any F'tl2lFrIrg-tltat
`lhé L1IIlg9 WW? aflllllélalféfl U‘ zuhlalned ’t.'1IFl‘.1ul’~.flk dame:
`Penluu Cnmpa-|yI based In Allegan, Mlthlgan, Is the n atlon'a large:t rnanutarturer at OTC
`pharmzucuullcal product-: lI:II lhe stare brand market Pmtgu mJrlul3rLl‘EE and cell: Jspuln.
`aI:etJ.rnInupnerI and Ityunmten tablets forpmatc label 1USlDlmBr' «NJ: 3: Wat Mm, Kmart,
`Targcl and 3aV~?‘I‘I'iy
`MIS Phaunnacentlut CDl|]_D:I'$PLlI1‘I BndImIuv1,C LIrr sctu-.9 m 4YIulztlI.1E& 3':4DlllV| mulurs
`tor Etl‘:lDllll’I‘> sum as Fuud LIun, Prue Cnuuuu, ullfl l1J'S V‘Ihult")dlti Club
`Lelnm I-hanh Prnduds.Inc.,o1(.arson,CalItIIrnIa. manuracturer amtamlnaphen t.anIst<. tm
`rustarrars ~:urI1 as 'IIVa‘—Mafl CD?1I:o Target mid B3I-2Ivi/
`LNKlIrlema1inrIa|I|uc I based In HauunaJ<Ie_ I‘IewYo’\_manmaI;luraIs and .'eI.s OTC mu:
`
`BlDL'.lLlL'.E cart.-I. ng aspmn and atelarnmutllagn Its EUalCmE'E ImI.I;lI: C:I-nuns». I-was Lab“).
`Eclerd Drug Company_ and Stop 3 Shop Supwmarket Comp my
`Phalmacuuucal Furmuattuns. Inc. I9 Based In Ednsun NFN Jam-y The Iurnpam
`l’I'Iil'IlJU(lUt?5.l&]I18l3 $?ll$_ and ‘1!strIb\.tEs nrm1'.(ta:IxntI~IIr‘mq 4.;/mn and atetamlnanhen
`sold‘ al relaIl beanng pnvale man: names In: CJ‘.'IL«"'VE'S sI.rI' 3: Km -1, U‘uE."It‘ Re3d&,E£l\elfl
`Drug _ urIIp;IrIy and I'v:.I.;mpn Co
`The SI-tfllfl merits
`Eath ultrle pxduused settlarhenls would uruhltalt the us snundunl Itunl !lIl‘JlBL‘li.'bEl||HIfi III9
`Prlenl ta Vrhlrh Its OTC drug Inoduzts L0TlaIrIInt] an analgeslc av-, r-Iarte in the unlled 5lalES A3
`ll1l’t9 FTC‘: pIIat"MaCE In USA’ LGSBS, ll*e wrlements ntrmtle 4 ‘safe ‘taitcf mid 3 IUWSYPE
`resgorudenls to rearesehtlhal a pmxtuctns mace Inthe Urll-ad Dtales it long as all. nnIrtI.a 4
`'dlI,n1(hEII1gIedIe’I13 OI camponertlaarts uIII\E pluducl are made In ins bnlled UIIEIPS arI1all,oI
`VIVKU-‘i|lY.i|I_|ahtleV1tplDy’EdlD manmzttura the prnduct s psrfnrrned In the Unlled State; The
`orders wnuld allow the respondents to rapresent that a product rontmnx-lg an Impurtvd attwe
`Inqrednenl I: "Pvotessed In tho Umted State: wIth Forelgn I-Igredmnta‘ when lnu mpresI:nIatIan
`I5 true and I; used ID descnlze :I prcduclthat has been 3IgmtII.:rIlly plmcssed In the Unlted
`513198
`In ¢t)'llIIUl\_ Ed: I ml the settlements Ecltlli-H3 a rlurntxer J! rvturdlu mama and relmfllnq
`requuemunta In dSSlil lhe FTC In muIIItu'IIn,t I.:.mpIIanI:e wllh the umera
`Thu: CarnmIss|on's ‘Mada In USA‘ Enlorcument Policy Statnmunt
`In DE(E*FI15I9I\99IV‘31Eli comprertensna palm r?vI:v\A the FYI; I on: .;:edthat'II/ads I’! U5!!-
`fldV&fll‘3INJ and Iabslmg Ila ms must COFIIIFILI: la rarltmm In tr: ‘;I1Iuw'.uaII;a I
`;LmdaI;I lrIal
`lite CUI'\'IVmS:IIUI'I lJ3UI|IUl\dlN I as BDDIIEU Undrl Inn. slartdard, urIuI..:IllE.l Ll S uhuxn .'ld.lVt'i
`must he subztanllaled Dv evldente Ihal a pludutl Is 'tall or vIflL.:IIv all" made In the Umtlzd Elatzs
`In addlluon, the aqenty Issued an Enforcement Pollcv Statement outtmmq lne factors the
`COI’nm‘SSlUI'I W|llLW1S>[1EI|l'| cetermlmng wnellu" 3 U S BIIr3l'I claim I5 ‘ueteptnre ‘In
`UeI.?U'IlJ9V I a3s_ the FTC If-Sued a busmess gu~de 'C:mp|vmg mtn the Made In USA Stmaard’
`Trns gI Icle Ll-':5(IILE.'S the In males ottne Wt 3 Standard LII «urn HJIFVS and awe exrvrcvlastz
`hen btstnesses .IndeIs'and hwtu Cflmply Imln the st2<nda'd Th: FTC alaa has aitnade In
`USA Web page («I ~ .. =I
`:_
`,' -
`:~, wtmr Includeslha ErtdIrerrIerl Polucy
`Btatvmcnt Inlolmalldn about entorcement Cltllufl’. 3nd Inre-;tIu.:bun:, and rzulwd ouclnazs
`Pdut man IVIJIEIIJIS
`The EOl'I'1IV‘II>>tD7I vote I: an :eattne (Iva nIcr.c"sd rnnsenl aI;r.2unIerIt; ard Llama them an the
`pwIII Ieuu W3: 50 A~.I.IInrIIaryu4IrIa uupwrd I.5’I‘.Elll s:,r-mnrrlt. Ml re [JJ‘J‘l3heJ nine
`F:-new Fwd zlkl EJIOVIIV Thu aqteemenla WII be -.mIaI:ta p.I:II. (um'fIB'I1V;Y 3] U4‘,"‘1_\/ILI
`DeIenItII:I I: max all:-I wIIIIr the CI7fnml5.1lLAI'IWtllUEllUL‘ vtlwlhgz (L m5kEll1t.'I'V1VIn.1l
`Comments shtuld be addressed ID the FTC, OVTIIE Dltfe 5E'l’E’laI’y EDI) Pann3yIvImIJ I'<Vbnue_
`NW, wIIsrungtun_ D C 20530
`.6 to! zettlernerl rurnosae mi. .411 dam VI'Il3r"HJ'E an
`NOTE: A Ianssznl agr-aernanl
`3:1rnIs~.IaII at 3 ma: V mare" when the Currn-m
`UP’;
`a can
`utlralbas $.41
`
`-an we In: II-rs or law ¢II‘Il\I>}§l'1PEll[‘(UlUIr‘ ’<II
`3-«I En"'* I.I:.. III
`'1 r1
`4.-I-I =Ir urn»: mrlVF5~ll
`In 4 I'I\'Il pw-Ialb, at 31
`,uuu per Ilav
`Cuwm oltha cnmfllalnls, the pruposed ctrnsan1aoreements,and an analrsls Month to am In
`Uuhllt Innlngm are ~1YJ1lL1DlHlIl]IY1lT|i FTIT5 wvr. «Its al I «I
`I
`A
`I‘
`I
`I and a|'~.u tram Ins
`FTL’ ‘e I 077w\lVI'\?'l'{ES’1OI\Sf:LE!\'XEl‘R037T‘ l:a_I.w Pennwwznla Avenue. N W . w munjzon,
`D C '.",5ZD Tne FTC Nmk: tut the Ionsurnvrtu prwcnt 'r1u1I.IIe'I‘, dtccnllaa I.tr'.l l.nV:lr
`0.13 nee 3 nrattlces In the In nketnlane and In prI:I‘I.1a.rIounatInrtnlreln czns umvrs .5931, sficp
`mu mm them To me .. :IInInIaInL urtc Flltm IIIrnr-rI.uurI Ll
`..IIy ul Isa I.DI"ErUV\1l'l\1DI—S :alI
`‘.oll—lrE
`I »HI I»? TCJ-{ELF (I -l177- 381-4 357), U! use the tomplalnl lnrm at
`I.
`III,n*.I I: rm.
`II?!
`IIIIII The FTC enter: lIl!E'|'IEl,(ElE71"-All(F‘1llIg. Idantnty melt and
`
`other 1: 3ud.yI-.-latefl ttlmpuilrlls Intu Connurhev Dentmet, a secutr, Jt1||!IE databaau avallablatu
`ttuttdtmh U“. VI and - Ilfftlllal law snfarcvmznl :D?|')E 2-. In Ire U 5 ma Immd
`Medla Cuntaa:
`Huwmn snapI.a_
`arms or man: flflarrs
`ID? 378 2719
`Slim Cumad:
`II.IrI LIm:~Il2 11' Lnuli 5 X035
`E>Im-an cI'Cw>.surrII2r F'IalE£lx:'I
`AU4‘ wul-tJnr1LI.I Alb-2883
`Inc rue Mus mg 3029 III-nIen L111 3051 (Aas) on 3111 (I-'errIna)U1Z 11:53 ILMQ U12 3059
`
`Home News
`About IIIII-IIr Arlzzus vumlc Lvmtts I $[>(3(!|Il!(!$
`kuleusa Date: November 5 MM
`
`

`
`
`
`Search
`
`Over—the—Cou_nter Drugs — Analgesics (pain relievers)
`
`Ads by Google
`Ne;v,Kngg_Pai.i1'1f;3_a,tmgnt — One Injettion — 6 lxfmiirlis Relief. Get Your Free Knee Pain Relief l-Lit. -
`
`
`
`Lo3v_Ba_c,};_Paln — Reliable Back Pain Treatment Get Relief with SpicierTech. -
`
` .m 1. 'j1r»_r.r.-5» « liral “DJ n
`
`Pairi l’rZ—ll>i'Jel‘E-, or anal"-521:3, are familiar products fciznd in most medi tine cabinets. These proclucts heip
`consumers relieve heaclac-hes, muscle aches, fever, and other 1:«ain~r-elaterl symptoms. \Vith so many
`lnraiid ri.air,i=, products and diffrzrent ntrerigths and formula: ,to=nla_v‘:: consumer has a variety of pain
`rr, lie-v:ii:J. Pl‘\JiL.l‘.l’.'t'EZ from which to choose. ‘/Jhat follows a re descriptions of the various pain ~relim/in;
`ap,-ants it‘-’all51bl€ as OTC drugs.
`
`
`.(-vT\3t}'lS-"1llC‘YllC acid is lmcvwn bv ci much more familiar name-—aspirin. It is a common analgesic, or drug
`that all:-viat-=2 pain witrioxit art;-ctin: i.‘CiX‘i-3r31JL‘iC.‘11r;"CS. in the fifth C"_'flli‘.1l"'.' E..C. , Greek physician
`Hippoiratec, considerecl "the father of medicine." used powder extracted from willow tree bark to treat
`pain and reclu-‘e fever. The arrive injredient, s-tdiiim Calicylate, was Cll?‘.i‘fiVE'i‘t"<'l centuries later. This
`irig,redi+,-nt was the predecessor to aizpiriii.
`
`IN 1897, GERMAN CHEMIST FELIX HOFFMAN DEVELOPED ASPIRIN WHILE TRYING TO
`FIND A WAY TO RELIEVE THE PAIN OF HIS FATHER'S ARTHRITIS. HE WORKED FOR A
`COMPANY CALLED BAYER.
`
`Aspirin works b_v inhibiting th>: release of a horinone—lil:e substanc»: called prc staglandin. This chemical
`affects bi-:»ct‘i vessels and me functions of blood platelet: and sensitizes nerve endings to pain. By llITl\Cll"|3
`the pr netaglariclin, aspirin affects blc ocl cl: tting, eases inflammation. and prevents the nerve ending at the
`nit-:~ of the pain from becoming atimulatel. It is used for headaches, muscle pa n, arthritis, and to reduce
`fi:\'ers.
`
`
`
`MIL}: lI‘1l1 can be usecl to redzice tn»: risk. of heart clise-359. (Photograph by
`Robert J. Huffman. Field .Vlarl' F‘uk-lii"atinii~s
`. Reprv:~Ju»:<.1‘l by permission.)
`
`"l"li-'- Buy,‘ ,1‘ Crtrripariy ran tin a(l‘v’k'rtl'..\.Ulk‘rit for its aspirin in the 19203 that I\.‘fld, ' DOES NOT AFFEFT
`THE Hl-'.AR’l‘." But Bayer was: wrong; aspirin does afie-‘t the heart. Fortiinately. aspirin has been found to
`l>~ beneficial In the heart, and .~. )IT1*.‘ of tc<liiy‘s aspirin eirl\.'ei'tiserrierits firuiturcz the American Heart
`1-‘msociati-an’ seal 01‘ approval.
`
`It is ectirnated that Americans use 80 million aspirin tablets a day, and most are not taken for aches mcl
`pains. They are used to rt'ClUCt‘ "he rig»: of heart disease. The FDA has approved the use of aspirin to treat
`2-;-riou: sardiiovaecular condititr 3 such :1: l'.v:z1rt attack and :.‘trol<e. It ha: been proven to reduce the risk
`of:
`
`- Strril:£—.»t and heart attacks in thrise who have already had one.
`. D»-In I1 -ir C(Jl'll}'IllC43Ill.TlS frtm a heart ittack if ta'»:i—n at the first sigiisof ore.
`- Re-curring blockage in those who have had heart bypass SUl‘$3r'-Ty to clear blocked arteries.
`
`

`
`The secret to .:ispirin's protective properties in relation to the cardiovascular system lies in aspirin’s
`ability to reduce the body's production of prostaglandin, which ca uses blood platelets to stick together.
`This phenomenon can eventually lead to blocked blood vessels and clots. A blaod clot in the brain causes
`stroke, while a blood clot in the heart causes heart attacks. By reducing the piostaslandin, the risk of
`heart attacks and strokes is reduced.
`
`The Arnerican Heart Association believes that out of the nine hundred thousand lives lost each year to
`cardiovascular disease, five to ten thousand could be saved if more people used aspirin at the first signs of
`a heart attack (intermittent chest pain, shortness of breath, and fatigue). In the important first moments
`of a heart attack, aspirin provides "head start" therapy and a better chance for survival.
`
`Because of its possible serious side effects. aspirin is not approved for daily use by healthy people who are
`not at risk for heart disease. For those who do need it, the recommended dose varies from 50 to 395
`milligrams daily. Above all, aspirin should never replace a healthy lifestyle.
`
`While it seems like a wonder drug. aspirin does have certain drawbacks. It can irritate the stomach lining,
`causing heartburn, pain, or nausea. Coating aspirin capsules helps reduce this irritation by preventing the
`release of the aspirin until it has passed through the stomach and into the small intestine; however,
`coating also slows the absorption of aspirin and increases the amount of time before it starts to work.
`Buffered aspirin reduces the acidity of the stomachs contents to lessen irritation. Taking aspirin with an
`antacid or after a meal will also reduce the stomach irritation. Because of these possible adverse effects,
`
`people should not take aspirin if they have a bleeding disorder, stomach ulcer, or gout (a painful disease
`of the joints, especially legs, hands, and feet).
`
`Other side effects include the fact that high doses of aspirin may cause ringing in the ears. Furthermore,
`if children or adolescents infected with chicken pox or influenza (flu) are given aspirin, they could cl evelop
`Reyes Syndrome, a sudden loss of consciousness that may cause death. Allergy sufferers should also
`watch their aspirin intake. If people are allergic to aspirin, they may have difficulty breathing or develop
`hives, itching, or swelling. Also, aspirin should not be given to someone directly before or after surgery
`becaii.-;e it decreases the bloods ability to clot, which could cause excessive bleeding.
`
`People who consume a lot of alcohol need to be careful, too~—liver damage and stomach bleeding can
`result when heavy drinkers use aspirin. Finally, aspirin should not be given to children under the age cf
`twelve or to pregnant women, especially during the last three months of pregnancy since it could cause
`complications during delivery.
`
`Acetaminophen is the generic (non -trademarked) name for the pain reliever found in brand name
`products such as Tylenol and Excedrin. It is also used to treat fever, headaches, and minor aches and
`pains. Acetaminophen works by affecting the brain and spinal cord, altering the perception of pain.
`Acetaminophen is similar to hormones that the brain produces called endorphins. These hormones stop
`the pain sensation from being transmitted from cell to cell. It reduces fevers by affecting the area of the
`brain that regulates temperature. Like aspirin, acetaminophen limits the production of prostaglandin in
`the brain. Aspirin affects prostaglandin production in the rest of the body as well, but acetaminophen only
`affects the brain. For this reason, acetaminophen does not reduce inflammation. It cannot affect swelling
`from arthritis, sprains, or muscle pain. It does have fewer side effects than either aspirin or ibuprofen
`(see below). Therefore, people with blood clots, ulcers, chicken pox, influenza, or gout can safely take
`acetaminophen instead of aspirin.
`
`Individuals with liver disease should not take acetaminophen; in fact, an overdose of this drug can cause
`seriouri liver and kidney damage. Like other pain relievers, this drug :3l10ulCl not be taken with alcoholic
`beverages. A risk of liver damage exists from combining large amounts of alcohol and acetaminophen. It
`should not be taken for more than ten days or by children under the age of twelve.
`
`Originally available only by prescription, this drug has been available in lower strength as an OTC pain
`reliever since 1984. Ibuprofen can be used to treat headaches, muscle aches, arthritis, swelling,
`menstrual pain, and to reduce fevers. Like aspirin, it works by inhibiting production c-f prostaglandin,
`which aids blood clotting and makes nerve endings sensitive.
`
`The possible side effects of using ibuprofen include drowsiness, heart—burn, upset stomach. nausea,
`vomiting, or dizziness. Taking the drug with food or milk often helps to avoid these problems. Pregnant
`women and people with diabetes or congestive heart failure should not take ibuprofen.
`
`Ibuprofen is a stronger analgesic than either aspirin or acetaminophen and a better anti-inflammatory
`than aspirin. It can be found in brand name products such as Advil, Motrin TB, and Nuprin.
`
`Ketoprofen and naproxen are pain relievers similar to ibuprofen. Ketoprofen has had OTC status since
`199

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket